Unknown

Dataset Information

0

A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer.


ABSTRACT: Elucidating the determinants of aggressiveness in lethal prostate cancer may stimulate therapeutic strategies that improve clinical outcomes. We used experimental models and clinical databases to identify GATA2 as a regulator of chemotherapy resistance and tumorigenicity in this context. Mechanistically, direct upregulation of the growth hormone IGF2 emerged as a mediator of the aggressive properties regulated by GATA2. IGF2 in turn activated IGF1R and INSR as well as a downstream polykinase program. The characterization of this axis prompted a combination strategy whereby dual IGF1R/INSR inhibition restored the efficacy of chemotherapy and improved survival in preclinical models. These studies reveal a GATA2-IGF2 aggressiveness axis in lethal prostate cancer and identify a therapeutic opportunity in this challenging disease.

SUBMITTER: Vidal SJ 

PROVIDER: S-EPMC4356948 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


Elucidating the determinants of aggressiveness in lethal prostate cancer may stimulate therapeutic strategies that improve clinical outcomes. We used experimental models and clinical databases to identify GATA2 as a regulator of chemotherapy resistance and tumorigenicity in this context. Mechanistically, direct upregulation of the growth hormone IGF2 emerged as a mediator of the aggressive properties regulated by GATA2. IGF2 in turn activated IGF1R and INSR as well as a downstream polykinase pro  ...[more]

Similar Datasets

| S-EPMC6614557 | biostudies-literature
| S-EPMC4775865 | biostudies-literature
| S-EPMC9618149 | biostudies-literature
| S-EPMC8102310 | biostudies-literature
| S-EPMC10386253 | biostudies-literature
2020-12-03 | GSE162564 | GEO
| S-EPMC7237425 | biostudies-literature
| S-EPMC8121828 | biostudies-literature
| PRJNA682218 | ENA
2023-01-14 | PXD028271 | Pride